Lirentelimab
Lirentelimab (AK002) is a humanized anti-sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) antibody that induces apoptosis of IL-5-activated eosinophils and inhibits IL-5-mediated mast cell activation, and is used in the study of refractory inert systemic mastocytosis and allergic conjunctivitis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
CAS Number
2283348-97-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1224960-01 0.02 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus Ribosome-binding factor A (rbfA)
Ask
View Details MBS1224960-02 0.1 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus Ribosome-binding factor A (rbfA)
Ask
View Details MBS1224960-03 0.02 mg (Yeast)
Recombinant Streptococcus equi subsp. zooepidemicus Ribosome-binding factor A (rbfA)
Ask
View Details 
MBS1224960-04 0.1 mg (Yeast)
Recombinant Streptococcus equi subsp. zooepidemicus Ribosome-binding factor A (rbfA)
Ask
View Details MBS1224960-05 0.02 mg (Baculovirus)
Recombinant Streptococcus equi subsp. zooepidemicus Ribosome-binding factor A (rbfA)
Ask
View Details